ABIVAX’s ABX464 Reduces HIV Reservoir in Blood in Second Phase 2a Clinical Trial
ABIVAX an innovative biotechnology company targeting the immune system to eliminate viral diseases using its...
In Preclinical Trials Inovio dMAb™ Constructs Shrink Prostate Tumors and Protect Against Lethal Antibiotic-Resistant...
Inovio Pharmaceuticals, Inc. announced that the development of its DNA-based monoclonal antibody program received a...
Datavant to Improve Clinical Trials with Artificial Intelligence launched by Roivant Sciences
Roivant Sciences, a global healthcare company focused on realizing the full value of promising biomedical...
Results of Subpopulation Analysis of Patients with Hepatitis B Virus Coinfection
Eisai Co., Ltd. has announced that the results of a subpopulation analysis of patients with...
Clinical studies with a new compound –PM14- in patients with solid tumors started by...
With the motivation of finding a solution to the unmet needs of patients with different...
Levicept Starts First-in-Human Phase I Trial of LEVI-04, A Novel Fusion Protein Therapy for...
Levicept Ltd., an asset-centric biotechnology company focused on the development of LEVI-04, a first-in-class treatment...
Successful Industrial GMP Manufacturing of RIBOXXIM, a Novel and Highly Potent Toll-like 3 Ligand...
RIBOXX PHARMACEUTICALS, a biotech company developing Toll-like-receptor (TLR) and RIG-I-like-Receptor (RLR) ligands, and ACCINOV, a...
Positive Dupilumab Topline Results From Phase 3 Trial In Uncontrolled Persistent Asthma Announced By...
Regeneron Pharmaceuticals, Inc. and Sanofi announced that the pivotal Phase 3 LIBERTY ASTHMA QUEST study...
Presented in VIVA Late Breaking Clinical Trials Medtronic IN.PACT Admiral DCB Global Two Year...
Medtronic plc data announced reinforce the durability and safety of the IN.PACT(TM) Admiral(TM) drug-coated balloon...
License Expansion for RGN-137 in Europe, S. Korea, Japan, Canada and Australia Completed By...
RegeneRx Biopharmaceuticals, Inc. (OTCQB: RGRX) ("the Company" or "RegeneRx"), a clinical-stage drug development company focused...
